Occlutech announces Completion of Patient Enrolment in Pilot S...
- Written by LATEST ASIANET NEWS RELEASES
- Published in Asia Net
SCHAFFHAUSEN, Switzerland, February 24, 2021, /PRNewswire-AsiaNet/-- Occlutech, a privately-held company, announced today the completion of patient enrolment in its pilot study to assess safety and efficacy of the novel Atrial Flow Regulator (AFR) in heart failure (HF) patients (PRELIEVE trial).PRELIEVE is a pr...
Authors: LATEST ASIANET NEWS RELEASES